GLP-1 Drugs: Entering a New Era in the World of Weight Loss

The drug semaglutide belongs to a class of medications known as Glucagon-like-peptide-1 receptor agonists, or GLP-1 receptor agonists. It mimics the GLP-1 hormone, released in the gut in response to eating. Semaglutide was designed for type 2 diabetes and has shown great potential in helping patients with diabetes. These GLP-1 analogues revealed several effects, including slowing stomach emptying, acting on the brain to reduce appetite, and boosting insulin release, which helps regulate blood sugar levels. It may also result in reduced risk of cancer, diabetes, and heart disease in people who are obese or overweight.

Search
Close this search box.